NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.02
-0.74 (-2.87%)
Aug 14, 2025, 11:51 AM - Market open
NAMS Employees
NewAmsterdam Pharma Company had 68 employees as of December 31, 2024. The number of employees increased by 39 or 134.48% compared to the previous year.
Employees
68
Change (1Y)
39
Growth (1Y)
134.48%
Revenue / Employee
$941,265
Profits / Employee
-$2,436,985
Market Cap
2.82B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68 | 39 | 134.48% |
| Dec 31, 2023 | 29 | 12 | 70.59% |
| Dec 31, 2022 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAMS News
- 8 days ago - NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewsWire
- 15 days ago - NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer's Disease Biomarkers at AAIC 2025 - GlobeNewsWire
- 23 days ago - NewAmsterdam Pharma to Present Alzheimer's Biomarker Data from BROADWAY Trial at AAIC 2025 - GlobeNewsWire
- 2 months ago - NewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical Trial - GlobeNewsWire
- 2 months ago - NewAmsterdam Pharma to Host R&D Day on June 11, 2025 - GlobeNewsWire
- 2 months ago - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June - GlobeNewsWire
- 3 months ago - NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference - GlobeNewsWire
- 3 months ago - NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - GlobeNewsWire